Ausgabe 3-4/2006
Inhalt (9 Artikel)
Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil
Moussa B. H. Youdim, Tamar Amit, Orit Bar-Am, Orly Weinreb, Mara Yogev-Falach
Common efficacy of psychotropic drugs in restoring stress-induced impairment of prefrontal plasticity
Nathalie Dupin, FranÇois Mailliet, Cyril Rocher, Karima Kessal, Michael Spedding, Therese M. Jay
The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia
John H. Krystal, D. Cyril D’Souza, JÜrgen Gallinat, Naomi Driesen, Anissa Abi-Dargham, Ismene Petrakis, Andreas Heinz, Godfrey Pearlson
Importance of clinical diagnoses for comorbidity studies in substance use disorders
Marta Torrens, Rocío Martin-Santos, Sharon Samet